Here’s what we know about upcoming vaccines and antibodies against RSV
Clinical trials suggest the preventives protect against the respiratory illness
About 3.6 million children were hospitalized and more than 100,000 died from RSV in 2019. Vaccines and preventive antibody injections in clinical trials may soon ease the burden of infection on kids and older adults too.